Literature DB >> 34432101

Circulating miRNAs and tissue iron overload in transfusion-dependent β-thalassemia major: novel predictors and follow-up guide.

Nashwa El-Khazragy1, Safa Matbouly2, Demiana H Hanna3, Nievin Ahmed Mahran4, Sally Abdallah Mostafa5, Bassam A Abdelrehim6, Yasmeen K Farouk6, Soha Abuelela7.   

Abstract

Tissue iron overload is a life-threatening scenario in children with transfusion-dependent β-thalassemia major, miRNAs that are involved in iron hemostasis could serve as therapeutic targets for control of iron overload. We aimed to find out the association between three iron-related miRNAs "miR-let-7d, miR-122, and miR-200b" and excess iron in tissues, in transfusion-dependent β-thalassemia major patients. Circulating miRNA expressions are measured in peripheral blood (PB) samples using qPCR of transfusion-dependent (TDT) β-thalassemia patients (n = 140) and normalized to non-transfusion-dependent (NTDT) β-thalassemia (n = 45). Results revealed that plasma expression levels of miR-let-7d and miR-200b were significantly downregulated in TDT patients; however, miR-122 was upregulated. In terms of tissue iron load, aberrant expression of miRNAs was significantly associated with increased-iron accumulation in hepatic and cardiac tissues. We concluded that circulating miRNAs are strong candidates that associate iron hemostasis in transfusion-dependent β-thalassemia major patients. And by extension, targeting miR-let-7d, miR-122, and miR-200 might serve as novel sensitive, specific and non-invasive predictor biomarkers for cellular damage under condition of tissue iron excess.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Blood transfusion; Circulating miRNAs; Iron overload; β-Thalassemia

Mesh:

Substances:

Year:  2021        PMID: 34432101     DOI: 10.1007/s00277-021-04639-0

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   4.030


  42 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 2.  How microRNAs control cell division, differentiation and death.

Authors:  Eric A Miska
Journal:  Curr Opin Genet Dev       Date:  2005-10       Impact factor: 5.578

3.  Hypogonadotrophic hypogonadism and diminished gonadal reserve accounts for dysfunctional gametogenesis in thalassaemia patients with iron overload presenting with infertility.

Authors:  Rekha Bajoria; Ratna Chatterjee
Journal:  Hemoglobin       Date:  2011-10-28       Impact factor: 0.849

4.  Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major.

Authors:  G M Brittenham; P M Griffith; A W Nienhuis; C E McLaren; N S Young; E E Tucker; C J Allen; D E Farrell; J W Harris
Journal:  N Engl J Med       Date:  1994-09-01       Impact factor: 91.245

5.  Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major.

Authors:  P T Telfer; E Prestcott; S Holden; M Walker; A V Hoffbrand; B Wonke
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

6.  Oral chelators in transfusion-dependent thalassemia major patients may prevent or reverse iron overload complications.

Authors:  Kallistheni Farmaki; Ioanna Tzoumari; Christina Pappa
Journal:  Blood Cells Mol Dis       Date:  2011-04-29       Impact factor: 3.039

Review 7.  Iron overload in MDS-pathophysiology, diagnosis, and complications.

Authors:  Norbert Gattermann; Eliezer A Rachmilewitz
Journal:  Ann Hematol       Date:  2010-10-12       Impact factor: 3.673

Review 8.  Role of iron deficiency and overload in the pathogenesis of diabetes and diabetic complications.

Authors:  Qiuju Liu; Liang Sun; Yi Tan; Guanjun Wang; Xu Lin; Lu Cai
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 9.  Non-transfusion-dependent thalassemias.

Authors:  Khaled M Musallam; Stefano Rivella; Elliott Vichinsky; Eliezer A Rachmilewitz
Journal:  Haematologica       Date:  2013-06       Impact factor: 9.941

10.  Identification of on-target mutagenesis during correction of a beta-thalassemia splice mutation in iPS cells with optimised CRISPR/Cas9-double nickase reveals potential safety concerns.

Authors:  Suad Alateeq; Dmitry Ovchinnikov; Timothy Tracey; Deanne Whitworth; Abdullah Al-Rubaish; Amein Al-Ali; Ernst Wolvetang
Journal:  APL Bioeng       Date:  2018-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.